We focused on the contribution of CD4+ T cells, CD16− monocytes and CD16+ monocytes to the IFN signature observed in patients with SLE and compared these results to the pure virus-induced signatures detected in healthy individuals immunised with the yellow fever vaccine (YFV). The gene discussed is IFNA1; the disease is systemic lupus erythematosus.